Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphoma

Follicular lymphoma: 2011 update on diagnosis and management

(2011) Arnold Freedman   AMERICAN JOURNAL OF HEMATOLOGY

Rituximab resistance

(2011) Andrew R. Rezvani et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Identifying Host Genetic Risk Factors in the Context of Public Health Surveillance for Invasive Pneumococcal Disease

(2011) Jairam R. Lingappa et al.   PLoS One

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Follicular non-Hodgkin's lymphoma

(2010) D. Hayashi et al.   CLINICAL RADIOLOGY

Inhibition of Membrane Complement Inhibitor Expression (CD46, CD55, CD59) by siRNA Sensitizes Tumor Cells to Complement Attack In Vitro

(2010) N. Geis et al.   CURRENT CANCER DRUG TARGETS

Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease

(2010) Sonia Davila et al.   NATURE GENETICS

The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation

(2009) P. Farinha et al.   BLOOD

Depletion of the C3 component of complement enhances the ability of rituximab-coated target cells to activate human NK cells and improves the efficacy of monoclonal antibody therapy in an in vivo model

(2009) S.-Y. Wang et al.   BLOOD

Risk of non-Hodgkin lymphoma in association with germline variation in complement genes

(2009) James R. Cerhan et al.   BRITISH JOURNAL OF HAEMATOLOGY

Associations between decay-accelerating factor polymorphisms and allergic respiratory diseases

(2009) T. Kawai et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Anti-CD20 monoclonal antibodies: historical and future perspectives

(2009) S. H. Lim et al.   HAEMATOLOGICA

Follicular Lymphoma in the United States: First Report of the National LymphoCare Study

(2009) Jonathan W. Friedberg et al.   JOURNAL OF CLINICAL ONCOLOGY

Statin Use and Prognosis in Patients With Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in the Rituximab Era

(2009) Grzegorz S. Nowakowski et al.   JOURNAL OF CLINICAL ONCOLOGY

The spectrum of phenotypes caused by variants in the CFH gene

(2009) Camiel J.F. Boon et al.   MOLECULAR IMMUNOLOGY

Prognostic Significance of CD55 Expression in Breast Cancer

(2008) J.-i. Ikeda et al.   CLINICAL CANCER RESEARCH

A Polymorphism in the Complement Component C1qA Correlates with Prolonged Response Following Rituximab Therapy of Follicular Lymphoma

(2008) E. Racila et al.   CLINICAL CANCER RESEARCH

Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma

(2008) A. Tzankov et al.   HAEMATOLOGICA

Treatment of follicular lymphoma: current status

(2008) Hervé Tilly et al.   LEUKEMIA & LYMPHOMA

Modulation of the antitumor immune response by complement

(2008) Maciej M Markiewski et al.   NATURE IMMUNOLOGY

The Role of Complement in the Mechanism of Action of Rituximab for B-Cell Lymphoma: Implications for Therapy

(2008) X. Zhou et al.   ONCOLOGIST

Non-small cell lung cancer cells produce a functional set of complement factor I and its soluble cofactors

(2007) Marcin Okroj et al.   MOLECULAR IMMUNOLOGY